Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-17 4:30 pm Unchanged |
2022-06-15 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 510,827 6.400% |
0 (Unchanged) |
Filing History |
| 2022-05-25 5:01 pm Purchase |
2022-05-24 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 510,827 6.400% |
178,056 (+53.51%) |
Filing History |
| 2022-05-10 4:58 pm Unchanged |
2022-05-09 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.170% |
0 (Unchanged) |
Filing History |
| 2022-05-02 5:27 pm Unchanged |
2022-04-28 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.170% |
0 (Unchanged) |
Filing History |
| 2022-04-21 1:09 pm Unchanged |
2022-04-20 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.170% |
0 (Unchanged) |
Filing History |
| 2022-03-16 08:00 am Unchanged |
2022-03-15 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.180% |
0 (Unchanged) |
Filing History |
| 2022-03-07 3:53 pm Unchanged |
2022-03-04 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.180% |
0 (Unchanged) |
Filing History |
| 2022-03-04 5:23 pm Purchase |
2022-02-22 | 13G | Catalyst Biosciences, Inc. CBIO |
Laurence W. Lytton | 472,615 5.900% |
442,952 (+1493.26%) |
Filing History |
| 2022-02-28 1:16 pm Purchase |
2022-02-24 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.180% |
18,178 (+5.78%) |
Filing History |
| 2022-02-22 7:04 pm Purchase |
2022-02-22 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 314,592 3.950% |
116,727 (+58.99%) |
Filing History |
| 2022-02-14 4:39 pm Sale |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-344,172 (Position Closed) |
Filing History |
| 2022-02-14 08:05 am Purchase |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Nantahala Capital Management, LLC | 700,173 8.800% |
227,249 (+48.05%) |
Filing History |
| 2022-02-11 5:55 pm Sale |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Stonepine Capital Management, LLC | 0 0.000% |
-543,781 (Position Closed) |
Filing History |
| 2022-02-11 4:18 pm Purchase |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
ORBIMED ADVISORS LLC | 342,423 4.300% |
342,423 (New Position) |
Filing History |
| 2022-02-11 4:16 pm Purchase |
2021-12-27 | 13G | Catalyst Biosciences, Inc. CBIO |
Renaissance Technologies LLC | 449,238 5.640% |
398,785 (+790.41%) |
Filing History |
| 2022-01-27 11:56 am Unchanged |
2022-01-26 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 197,866 2.480% |
0 (Unchanged) |
Filing History |
| 2022-01-18 06:15 am Sale |
2022-01-14 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 0 0.000% |
-475,856 (Position Closed) |
Filing History |
| 2022-01-18 06:12 am Purchase |
2022-01-13 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 475,856 5.980% |
193,267 (+68.39%) |
Filing History |
| 2022-01-05 5:29 pm Purchase |
2022-01-04 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 197,866 2.480% |
30,424 (+18.17%) |
Filing History |
| 2021-10-25 9:08 pm Purchase |
2021-10-25 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 167,442 2.110% |
66,323 (+65.59%) |
Filing History |